ALBERTO BERCEDO SANZ

Dr. ALBERTO BERCEDO SANZ

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
KMKarina Mayoral
Karina Mayoral
CLCatalina Lizano-Barrantes
Catalina Lizano-Barrantes
VZVíctor Zamora
Víctor Zamora
APAngels Pont
Angels Pont
CMCarme Miret
Carme Miret
MFMontserrat Ferrer
Montserrat Ferrer
Background: We aim to assess the impact of montelukast on paediatric patients with asthma/allergic rhinitis, measured using patient-reported outcome measures, compared with other treatments or placebo.Methods: Protocol registration CRD42020216098 (www.crd.york.ac.uk/PROSPERO). MEDLINE and Embase databases were used to conduct the search. Two authors independently selected studies and extracted data, and a third reviewer resolved discrepancies. Meta-analyses were constructed to estimate the standardised mean difference (SMD) using a random-effects model.Results: Out of 3937 articles identified, 49 studies met the inclusion criteria, mostly randomised clinical trials (sample sizes: 21–689 patients). The SMD of change pooled estimators for the global, mental and physical domains of health-related quality of life were not statistically significant. For daytime and night-time symptoms scores, the SMD (95% CI) was in favour of inhaled corticosteroids (−0.12, −0.20– −0.05 and −0.23, −0.41– −0.06, respectively). The pooled estimator for global asthma symptoms was better for montelukast when compared with placebo (0.90, 0.44–1.36).Conclusions: The synthesis of the available evidence suggests that, in children and adolescents, montelukast was effective in controlling asthma symptoms when compared with placebo, but inhaled corticosteroids were superior in controlling symptoms, especially at night-time. These findings of our systematic review concur with current guidelines for asthma treatment.

2 January 2021 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
KMK. Mayoral
K. Mayoral
OGO. Garin
O. Garin
MCM. A. Caballero-Rabasco
M. A. Caballero-Rabasco
MPM. Praena-Crespo
M. Praena-Crespo
ASALBERTO BERCEDO SANZ
ALBERTO BERCEDO SANZ
Alexandra L DimaAlexandra L Dima
Alexandra L Dima

6 March 2023 in World Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
CLCatalina Lizano-Barrantes
Catalina Lizano-Barrantes
OGOlatz Garin
Olatz Garin
Alexandra L DimaAlexandra L Dima
Alexandra L Dima
KMKarina Mayoral
Karina Mayoral
APAngels Pont
Angels Pont
MBMarijn de Bruin
Marijn de Bruin

15 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Alberto Arnedo-PenaAlberto Arnedo-Pena
Alberto Arnedo-Pena
SFSaeed Fattahi
Saeed Fattahi
Ines Aguinaga-Ontoso  BA(Psichology) MD  MPH PhDInes Aguinaga-Ontoso BA(Psichology) MD MPH PhD
Ines Aguinaga-Ontoso BA(Psichology) MD MPH PhD
ASALBERTO BERCEDO SANZ
ALBERTO BERCEDO SANZ
CDCarlos González Díaz
Carlos González Díaz
TGthe Spanish GAN group
the Spanish GAN group
Background/Objective: In the multifactorial genesis of asthma, environmental factors are critical, including sun exposure, either measured by sunshine hours (SH) or global solar surface irradiance (GSSI). The objective of this study is to estimate the association between sun exposure and the prevalence of asthma in Spanish schoolchildren (6-7 year-old) and adolescents (13-14 year-old) from 6 geographic centers of Spain (A Coruña, Bilbao, Canta-bria, Cartagena, Pamplona and Salamanca) included in the Global Asthma Network (GAN) study during the period 2016-2019. Methods: Measurements of SH and GSSI were obtained from the Spanish “Agencia Estatal de Meteorología”. A semi-individual design was used, and multilevel logistic regression models were employed with adjustments for age, sex, temperature, relative humidity and gross domestic product, considering center as the reference level. Results: Increments of SH and GSSI were associated with decreases of the prevalence of “asthma ever” in both the 6-7 and 13-14 year-old groups. An increase of 100 hours of an-nual sunshine was associated with a decline in “asthma ever” in schoolchildren (adjusted odds ratio [aOR] = 0.82; 95% confidence interval [CI] 0.79-0.85), and adolescents (aOR = 0.90; 95% CI 0.87-0.94). An increase of one kWh m-2 day-1 in GSSI was associated with a decrease in the prevalence of “asthma ever” in schoolchildren (aOR = 0.15; 95% CI 0.10-0.23) and adolescents (aOR = 0.37; 95% CI 0.25-0.54). Conclusions: The results suggest that sun exposure, either measured by SH or GSSI, might be a protective factor for the prevalence of asthma in schoolchildren and adolescents. This information could be useful in the prevention of this condition.

12 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Alberto Arnedo-PenaAlberto Arnedo-Pena
Alberto Arnedo-Pena
SFSaeed Fattahi
Saeed Fattahi
Ines Aguinaga-Ontoso  BA(Psichology) MD  MPH PhDInes Aguinaga-Ontoso BA(Psichology) MD MPH PhD
Ines Aguinaga-Ontoso BA(Psichology) MD MPH PhD
ASALBERTO BERCEDO SANZ
ALBERTO BERCEDO SANZ
CGCarlos González-Díaz
Carlos González-Díaz
TGthe Spanish GAN Group
the Spanish GAN Group
Background/Objective: In the multifactorial etiology of asthma, environmental factors, including sun exposure, measured either by sunshine hours (SHs) or global solar surface irradiance (GSSI), are critical. The objective of this study is to estimate the association between sun exposure and the prevalence of asthma in Spanish schoolchildren (6–7 years old) and adolescents (13–14 years old) from six geographic centers in Spain (A Coruña, Bilbao, Cantabria, Cartagena, Pamplona and Salamanca) included in the Global Asthma Network (GAN) study during 2016–2019. Methods: Measurements of SHs and GSSI were obtained from the Spanish “Agencia Estatal de Meteorología”. A semi-individual cross-sectional design was used, and multilevel logistic regression models were employed, with adjustments for age, sex, temperature, relative humidity and gross domestic product, taking the center as the reference level. Permutation tests were performed to account for the low number of centers. Results: Increases in both SHs and GSSI were associated with a lower prevalence of “asthma ever” in the 6–7 and 13–14 years age groups. An increase of 100 annual sunshine hours was associated with a lower prevalence of “asthma ever” among schoolchildren (adjusted odds ratio [aOR] = 0.82; 95% confidence interval [CI], 0.79–0.85); from the crude model, permutation p = 0.08. In adolescents, the corresponding estimates were aOR = 0.90 (95% CI, 0.87–0.94); from the crude model, permutation p = 0.02. An increase of 1 kWh m−2 day−1 in GSSI was associated with a lower prevalence of “asthma ever” among schoolchildren (aOR = 0.15; 95% CI, 0.10–0.23); from the crude model, permutation p = 0.25. In adolescents, the corresponding estimates were aOR = 0.37 (95% CI, 0.25–0.54); from the crude model, permutation p = 0.01. Conclusions: The results of this study suggest that sun exposure, measured either as SHs or GSSI, may be protective against asthma in adolescents. In contrast, the association between sun exposure and the prevalence of “asthma ever” in schoolchildren was not significant, although it followed a similar trend. Confirmation of these findings in other geographical settings could improve our understanding of the role of sun exposure in asthma prevention and control.